TrianglePUBLICATIONS · 12879472
Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer
- Publication date
- 2003 Aug 1
- First author
- Danson S
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Danson S
- type
- Author
- name
- Middleton MR
- type
- Author
- name
- O'Byrne KJ
- type
- Author
- name
- Clemons M
- type
- Author
- name
- Ranson M
- type
- Author
- name
- Hassan J
- type
- Author
- name
- Anderson H
- type
- Author
- name
- Burt PA
- type
- Author
- name
- Fairve-Finn C
- type
- Author
- name
- Stout R
- type
- Author
- name
- Dowd I
- type
- Author
- name
- Ashcroft L
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Danson S
- type
- Author
- name
- Middleton MR
- type
- Author
- name
- O'Byrne KJ
- type
- Author
- name
- Clemons M
- type
- Author
- name
- Ranson M
- type
- Author
- name
- Hassan J
- type
- Author
- name
- Anderson H
- type
- Author
- name
- Burt PA
- type
- Author
- name
- Fairve-Finn C
- type
- Author
- name
- Stout R
- type
- Author
- name
- Dowd I
- type
- Author
- name
- Ashcroft L
- type
- Author
- bibliography ids
- nci-bib-b67732f8ec17bf7eadd2ed98
- book metadata
- content sha256
- 1da6a7553fe465a85dacd7a14ca9218976041aa8656ca106d9555262080dd966
- document type
- citation
- dois
- 10.1002/cncr.11535
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:12879472
- immutable id
- pubmed:12879472@1da6a7553fe465a85dacd7a14ca9218976041aa8656ca106d9555262080dd966
- journal
- abbreviation
- Cancer
- issn electronic
- Source null
- issn print
- 0008-543X
- issue
- 3
- name
- Cancer
- nlm unique id
- 0374236
- pages
- 542-53
- volume
- 98
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 12879472
- provenance
- batch id
- 2d0158fe73b50bb1a4bf
- provider
- NCBI PubMed ESummary
- record sha256
- a9dbba44dba3f75091a908c2bc8d1265b7dd51d4bf36e77744e24a0840c4ef53
- response sha256
- d46de44782d91ef4394e88a69f82b1ee22148e8c4cf1534eb36c80479345e70e
- retrieved at
- 2026-09-09T23:45:50.935339+00:00
- publication date
- display
- 2003 Aug 1
- precision
- day
- year
- 2003
- publication types
- Clinical Trial
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma.
Preserved source evidence · Not medical advice